Natural killer cell receptors and MHC class I interactions

Current Opinion in Immunology

Volumn 9, Issue 1, 1997, Pages 126-131

  Lanier, Lewis L ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ALLELE; ARTICLE; CYTOTOXICITY; KILLER CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; NATURAL KILLER CELL; T LYMPHOCYTE; TARGET CELL;

EID: 0031045797     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(97)80169-0     Document Type: Article

References (63)

1. Kärre K, Ljunggren HG, Piontek G, Kiessling R. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defense strategy. Nature. 319:1986;675-678.
2. Liao N-S, Bix M, Zijlstra M, Jaenisch R, Raulet D. MHC class I deficiency: susceptibility to natural killer (NK) cells and impaired NK activity. Science. 253:1991;199-202.
3. + IL-2-activated natural killer cells. Nature. 358:1992;66-70.
4. Long EO, Colonna M, Lanier LL. Inhibitory MHC class I receptors on NK and T cells: a standard nomenclature. of special interest Immunol Today. 17:1996;100 A proposal to establish a common nomenclature for the newly discovered family of human receptors related to the Ig superfamily that are receptors for MHC class I.
5. Yokoyama WM, Kehn PJ, Cohen DI, Shevach EM. Chromosomal location of the Ly-49 (A1. YE1/48) multigene family: genetic association with the NK1.1 antigen. J Immunol. 145:1990;2353-2358.
6. Wong S, Freeman JD, Kelleher C, Mager D, Takei F. Ly-49 multigene family: new members of a superfamily of type II membrane proteins with lectin-like domains. J Immunol. 147:1991;1417-1423.
7. Smith HRC, Karlhofer FM, Yokoyama WM. Ly-49 multigene family expressed by IL-2-activated NK cells. J Immunol. 153:1994;1068-1079.
8. Dissen E, Ryan JC, Seaman WE, Fossum S. An autosomal dominant locus, Nka, mapping to the Ly-49 region of a rat natural killer (NK) gene complex, controls NK cell lysis of allogeneic lymphocytes. J Exp Med. 183:1996;2197-2207.
9. Brennan J, Mahon G, Mager DL, Jefferies WA, Takei F. Recognition of class I major histocompatibility complex molecules by Ly-49: specificities and domain interactions. of special interest J Exp Med. 183:1996;1553-1559 Studies demonstrating that Ly-49 receptors are expressed as homodimers and mapping the binding site on Ly-49 for H-2 ligands.
10. Sundback J, Karre K, Sentman CL. Cloning of minimally divergent allelic forms of the NK receptor Ly-49C, differentially controlled by host genes in the MHC and NK gene complexes. J Immunol. 157:1996;3936-3942.
11. Stoneman ER, Bennett M, An J, Chesnut KA, Scheerer JB, Siciliano MJ, Kumar V, Mathew PA. Cloning and characterization of 5E6 (Ly-49C), a receptor molecule expressed on a subset of murine natural killer cells. J Exp Med. 182:1995;305-314 Definition of the H-2 specificity of the murine Ly-49C and Ly-49G2 (see [13]) receptors and evidence for allelic polymorphism of Ly-49C.
12. Silver ET, Elliott JF, Kane KP. Alternatively spliced Ly-49D and H transcripts are found in IL-2 activated NK cells. Immunogenetics. 44:1996;478-482.
13. Mason LH, Ortaldo JR, Young HA, Kumar K, Bennett M, Anderson SK. Cloning and functional characteristics of murine LGL-1: a member of the Ly-49 gene family (Ly-49G2). of special interest J Exp Med. 182:1995;293-304 See annotation [11].
14. Brennan J, Mager D, Jefferies W, Takei F. Expression of different members of the Ly-49 gene family defines distinct natural killer cell subsets and cell adhesion properties. J Exp Med. 180:1994;2287-2295.
15. Held W, Roland J, Raulet DH. Allelic exclusion of Ly49-family genes encoding class I MHC-specific receptors on NK cells. of outstanding interest Nature. 376:1995;355-358 Evidence for preferential expression of a single allele of Ly-49 genes in NK cells.
16. Colonna M, Samaridis J. Cloning of Ig-superfamily members associated with HLA-C and HLA-B recognition by human NK cells. of outstanding interest Science. 268:1995;405-408 See annotation [18].
17. Wagtmann N, Biassoni R, Cantoni C, Verdiani S, Malnati MS, Vitale M, Bottino C, Moretta L, Moretta A, Long EO. Molecular clones of the p58 natural killer cell receptor reveal Ig-related molecules with diversity in both the extra- and intracellular domains. of outstanding interest Immunity. 2:1995;439-449 See annotation [18].
18. D'Andrea A, Chang C, Franz-Bacon K, McClanahan T, Phillips JH, Lanier LL. Molecular cloning of NKB1: a natural killer cell receptor for HLA-B allotypes. of outstanding interest J Immunol. 155:1995;2306-2310 This paper along with [16,17], reports the molecular cloning of the KIR molecules.
19. Baker E, D'Andrea A, Phillips JH, Sutherland GR, Lanier LL. Natural killer cell receptor for HLA-B allotypes, NKB1: map position 19q13.4. Chrom Res. 3:1995;511.
20. + natural killer (NK) cells by the expression of clonally distributed functional surface molecules: correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition. J Exp Med. 172:1990;1589-1598.
21. Lanier LL, Gumperz J, Parham P, Melero I, Lopez-Botet M, Phillips JH. The NKB1 and HP-3E4 NK cell receptors are structurally distinct glycoproteins and independently recognize polymorphic HLA-B and HLA-C molecules. J Immunol. 154:1995;3320-3327.
22. Biassoni R, Cantoni C, Falco M, Verdiani S, Bottino C, Vitale M, Conte R, Poggi A, Moretta A, Moretta L. The human leukocyte antigen (HLA)-C-specific "activitory" or "inhibitory" natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions. of outstanding interest J Exp Med. 183:1996;645-650 Studies demonstrating the KIR isoforms may activate, as well as inhibit, NK-cell-mediated cytotoxicity.
23. Bottino C, Sivori S, Vitale M, Cantoni C, Falco M, Pende D, Morelli L, Augugliaro R, Semenzato G, Biassoni R, et al. A novel surface molecule homologous to the p58/p50 family of receptors is selectively expressed on a subset of human natural killer cells and induces both triggering of cell functions and proliferation. Eur J Immunol. 26:1996;1816-1824.
24. Moretta L, Sivori S, Vitale M, Pende D, Morelli L, Augugliaro R, Bottino C, Moretta L. Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells. J Exp Med. 182:1995;875-884.
25. Wagtmann N, Rajagopalan S, Winter CC, Peruzzi M, Long EO. Killer cell inhibitory receptors specific for HLA-C and HLA-B identified by direct binding and by functional transfer. of outstanding interest Immunity. 3:1995;801-809 Formal proof by gene transfer and binding studies that the KIR molecules are directly responsible for HLA class I recognition and inhibition of NK-cell-mediated cytotoxicity.
26. Pende D, Biassoni R, Cantoni C, Verdiani S, Falco M, DiDonato C, Accame O, Bottino C, Moretta A, Moretta L. The natural killer cell receptor specific for HLA-A allotypes: a novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140-kD disulphide-linked dimer. J Exp Med. 184:1996;505-518.
27. Gumperz J, Parham P. The enigma of the natural killer cell. Nature. 378:1995;245-248.
28. + T lymphocytes. I. Inhibition of the IL-2 dependent proliferation by anti-Kp43 monoclonal antibody. J Immunol. 144:1990;3238-3247.
29. Chang C, Rodriguez A, Carretero M, Lopez-Botet M, Phillips JH, Lanier LL. Molecular characterization of human CD94: a type II membrane glycoprotein related to the C-type lectin superfamily. Eur J Immunol. 25:1995;2433-2437.
30. Moretta A, Vitale M, Sivori S, Bottino C, Morelli L, Augugliaro R, Barbaresi M, Pende D, Ciccone E, Lopez-Botet M, Moretta L. Human natural killer cell receptors for HLA-class I molecules. Evidence that the Kp43 (CD94) molecule functions as receptor for HLA-B alleles. J Exp Med. 180:1994;545-555.
31. Phillips JH, Chang C, Mattson J, Gumperz JE, Parham P, Lanier LL. CD94 and a novel associated protein (94AP) form a NK cell receptor involved in the recognition of HLA-A, -B, and -C allotypes. of outstanding interest Immunity. 5:1996;163-172 Evidence that CD94 forms disulfide-linked heterodimers that are involved in the recognition of HLA-A, -B, and -C allotypes.
32. Pérez-Villar JJ, Melero I, Rodriguez A, Carretero M, Aramburu J, Sivori S, Orengo AM, Moretta A, Lopez-Botet M. Functional ambivalence of the Kp43 (CD94) NK cell-associated surface antigen. of special interest J Immunol. 154:1995;5779-5788 Demonstration that CD94 receptors are functionally heterogeneous and may inhibit or activate NK cell clones.
33. Kane KP. Ly-49 mediates EL4 lymphoma adhesion to isolated class I major histocompatibility complex molecules. J Exp Med. 179:1994;1011-1015.
34. Daniels B, Karlhofer FM, Seaman WE, Yokoyama WM. A natural killer cell receptor specific for a major histocompatibility complex class I molecule. J Exp Med. 180:1994;687-692.
35. Orihuela M, Margulies DH, Yokoyama WM. The NK cell receptor Ly-49A recognizes a peptide-induced conformational determinant on its MHC class I ligand. of special interest Proc Natl Acad Sci USA. 93:1996;11792-11797 Further mapping of the H-2 specificity of the Ly-49 receptors and an indication that peptides are required to create the proper conformation for Ly-49 binding.
36. d molecules on target cell protection and natural killer cell specificity in transgenic mice. of special interest Eur J Immunol. 26:1996;2127-2132 Demonstration that only the extracellular domains of H-2 are necessary for Ly-49 function.
37. d, has a functional carbohydrate recognition domain. Immunity. 1:1994;785-792.
38. Brennan J, Takei F, Wong S, Mager DL. Carbohydrate recognition by a natural killer cell receptor, Ly-49C. J Biol Chem. 270:1995;9691-9694.
39. Fan QR, Garboczi DN, Winter CC, Wagtmann N, Long EO, Wiley DC. Direct binding of a soluble natural killer cell inhibitory receptor to a soluble human leukocyte antigen-Cw4 class I major histocompatibility complex molecule. of outstanding interest Proc Natl Acad Sci USA. 93:1996;7178-7183 An elegant study showing binding of KIR and HLA-C molecules in solution.
40. Dohring C, Colonna M. Human natural killer cell inhibitory receptors bind to HLA class I molecules. Eur J Immunol. 26:1996;365-369.
41. Gumperz JE, Litwin V, Phillips JH, Lanier LL, Parham P. The Bw4 public epitope of HLA-B molecules confers reactivity with NK cell clones that express NKB1, a putative HLA receptor. J Exp Med. 181:1995;1133-1144.
42. Colonna M, Borsellino G, Falco M, Ferrara GB, Strominger JL. HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1- and NK2-specific natural killer cells. Proc Natl Acad Sci USA. 90:1993;12000-12004.
43. Biassoni R, Falco M, Cambiaggi A, Costa P, Verdiani S, Pende D, Conte R, DiDonato C, Parham P, Moretta L. Single amino acid substitutions can influence the NK-mediated recognition of HLA-C molecules. Role of serine-77 and lysine-80 in the target cell protection from lysis mediated by "group 2" or "group 1" NK clones. J Exp Med. 182:1995;605-610.
44. Dohring C, Scheidegger D, Samaridis J, Cella M, Colonna M. A human killer inhibitory receptor specific for HLA-A. J Immunol. 156:1996;3098-3101.
45. Ciccone E, Pende D, Nanni L, Di Donato C, Viale O, Beretta A, Vitale M, Sivori S, Moretta A, Moretta L. General role of HLA class I molecules in the protection of target cells from lysis by natural killer cells: evidence that the free heavy chains of class I molecules are not sufficient to mediate the protective effect. Int Immunol. 7:1995;393-400.
46. Malnati MS, Peruzzi M, Parker KC, Biddison WE, Ciccone E, Moretta A, Long EO. Peptide specificity in the recognition of MHC class I by natural killer cell clones. of outstanding interest Science. 267:1995;1016-1018 The first evidence that peptides bound to HLA-27 influence recognition of MHC class I by NK cells.
47. Correa I, Raulet DH. Binding of diverse peptides to MHC class I molecules inhibits target cell lysis by activated natural killer cells. of outstanding interest Immunity. 2:1995;61-71 A study indicating that either self or foreign peptides are sufficient for Ly-49 function.
48. *2705. of special interest J Exp Med. 184:1996;1585-1590 Formal proof that a single KIR-3D molecule can discriminate between peptides bound to HLA-B27.
49. *2705 by specific natural killer cells. of special interest J Immunol. 157:1996;3350-3356 Experiments demonstrating that residues seven and eight of peptides bound to HLA-B27 are important for KIR-3D recognition.
50. Law C-L, Sidorenko SP, Chandran KA, Zhao Z, Shen S-H, Fischer EH, Clark EA. CD22 associates with protein tyrosine phosphatase 1C, Syk, and phospholipase Cγ1 upon B cell activation. J Exp Med. 184:1996;547-560.
51. D'Ambrosio D, Hippen KL, Minskoff SA, Mellman I, Pani G, Siminovitch KA, Cambier JC. Recruitment and activation of PTP1C in negative regulation of antigen receptor signaling by FcγRIIBI. Science. 268:1995;293-297.
52. Burshtyn DN, Scharenberg AM, Wagtmann N, Rajagopalan S, Berrada K, Yi T, Kinet J-P, Long EO. Recruitment of tyrosine phosphatase HCP by the killer cell inhibitory receptor. of outstanding interest Immunity. 4:1996;77-85 The first report providing a molecular mechanism for KIR inhibition of NK-cell-mediated cytotoxicity.
53. Olcese L, Lang P, Vely F, Cambiaggi A, Marguet D, Blery M, Hippen KL, Biassoni R, Moretta A, Moretta L, et al. Human and mouse killer-cell inhibitory receptors recruit PTP1C and PTP1D protein tyrosine phosphatases. of special interest J Immunol. 156:1996;4531-4534 See annotation [55].
54. Campbell KS, Dessing M, Lopez-Botet M, Cella M, Colonna M. Tyrosine phosphorylation of a human killer inhibitory receptor recruits protein tyrosine phosphatase 1C. of special interest J Exp Med. 184:1996;93-100 See annotation [55].
55. Fry A, Lanier LL, Weiss A. Phosphotyrosines in the KIR motif of NKB1 are required for negative signaling and for association with PTP1C. of special interest J Exp Med. 184:1996;295-300 This paper, along with [53,54], provides further support that SHP-1 is involved in inhibition of T and NK cell activation mediated by the human KIRs and murine Ly-49 receptors.
56. Yu YYL, Kumar V, Bennett M. Murine natural killer cells and marrow graft rejection. Ann Rev Immunol. 10:1992;189-214.
57. Yu YYL, George T, Dorfman JR, Roland J, Kumar V, Bennett M. The role of Ly49A and 5E6 (Ly49C) molecules in hybrid resistance mediated by murine natural killer cells against normal T cell blasts. of special interest Immunity. 4:1996;67-76 Evidence that hybrid resistance to bone marrow allografts is mediated by inhibitory Ly-49 receptors.
58. Glas R, Waldenstrom M, Hoglund P, Klein G, Karre K, Ljunggren H-G. Rejection of tumors in mice with severe combined immunodeficiency syndrome determined by the major histocompatibility complex. Class I expression on the graft. Cancer Res. 55:1995;1911-1916.
59. Maudsley DJ, Pound JD. Modulation of MHC antigen expression by viruses and oncogenes. Immunol Today. 12:1991;429-431.
60. Ferrini S, Cambiaggi A, Meazza R, Sforzini S, Marciano S, Mingari MC, Moretta L. T cell clones expressing the natural killer cell-related p58 receptor molecule display heterogeneity in phenotypic properties and p58 function. Eur J Immunol. 24:1994;2294-2298.
61. Phillips JH, Gumperz JE, Parham P, Lanier LL. Superantigen-dependent, cell-mediated cytotoxicity inhibited by MHC class I receptors on T lymphocytes. of outstanding interest Science. 268:1995;403-405 Demonstrates that KIR molecules can regulate T cell responses to super-antigens.
62. D'Andrea A, Chang C, Phillips JH, Lanier LL. Regulation of T cell lymphokine production by killer cell inhibitory receptor recognition of self HLA class I alleles. of special interest J Exp Med. 184:1996;789-794 Implicates KIRs in the regulation of cytokine production, as well as in cytotoxicity.
63. Lazetic S, Chang C, Houchins JP, Lanier LL, Philips JH. Human NK cell receptors involved in MHC class I recognition are disulfide-linked heterodimers of CD94 and NKG2 subunits. of outstanding interest J Immunol. 157:1996;4741-4745 Identification of the CD94-associated protein.